SIMETHICONE CAPSULES USP, 125 MG

SIMETHICONE CAPSULES USP, 125 MG was reported 491 times

SIMETHICONE CAPSULES USP, 125 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAPILLARY FRAGILITY DECREASED 1 0.5000
1 TRACHEOSTOMY CLOSURE 1 0.1667
2 CANNABIS INTERACTION 1 0.0769
3 ALEXITHYMIA 1 0.0200
4 BLOOD PRESSURE SYSTOLIC 1 0.0135
5 BACTERIAL TRACHEITIS 1 0.0123
6 PRECANCEROUS MUCOSAL LESION 1 0.0122
7 INTESTINE TRANSPLANT REJECTION 1 0.0104
8 SMALL INTESTINE CARCINOMA METASTATIC 1 0.0096
9 TRACHEAL INFLAMMATION 1 0.0092
10 BENIGN SALIVARY GLAND NEOPLASM 1 0.0086
11 TRACHEOSTOMY INFECTION 1 0.0082
12 TRACHEAL OEDEMA 1 0.0068
13 EAR TUBE INSERTION 2 0.0068
14 CONFUSIONAL AROUSAL 1 0.0062
15 INTESTINAL STRANGULATION 1 0.0062
16 THORACIC OPERATION 1 0.0061
17 MEDIASTINUM NEOPLASM 1 0.0060
18 SCROTAL ERYTHEMA 1 0.0060
19 SENSORY PROCESSING DISORDER 1 0.0059
20 TRACHEOSTOMY MALFUNCTION 1 0.0048
21 RECTAL SPASM 1 0.0043
22 POST PROCEDURAL OEDEMA 1 0.0043
23 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
24 ENAMEL ANOMALY 1 0.0035
25 DERMATILLOMANIA 2 0.0034
26 TUMOUR COMPRESSION 1 0.0031
27 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
28 DERMATITIS DIAPER 2 0.0028
29 STOMAL HERNIA 1 0.0027
30 PROSTATIC SPECIFIC ANTIGEN DECREASED 1 0.0026
31 TRACHEITIS 2 0.0026
32 CROUP INFECTIOUS 2 0.0025
33 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
34 DEVICE COLOUR ISSUE 1 0.0025
35 LARYNGEAL PAIN 1 0.0025
36 GINGIVAL BLISTER 1 0.0023
37 NAIL INFECTION 3 0.0021
38 ALCOHOL INTERACTION 4 0.0021
39 ARTIFICIAL CROWN PROCEDURE 1 0.0020
40 BLADDER MASS 1 0.0020
41 MYELOID LEUKAEMIA 1 0.0020
42 LIGAMENT PAIN 1 0.0019
43 EXPULSION OF MEDICATION 1 0.0019
44 STOMA SITE IRRITATION 1 0.0018
45 GALLBLADDER NON-FUNCTIONING 1 0.0018
46 VACCINATION SITE PAIN 1 0.0017
47 SUTURE INSERTION 1 0.0017
48 XEROPHTHALMIA 1 0.0017
49 OPEN ANGLE GLAUCOMA 1 0.0016
50 ENTEROCOCCUS TEST POSITIVE 1 0.0015
51 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
52 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
53 SERRATIA INFECTION 1 0.0013
54 OXYGEN CONSUMPTION INCREASED 3 0.0013
55 DYSBIOSIS 1 0.0012
56 OESOPHAGEAL RUPTURE 1 0.0012
57 DENTAL DISCOMFORT 1 0.0012
58 PERIORBITAL PAIN 1 0.0012
59 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
60 PSEUDOMONAL BACTERAEMIA 1 0.0012
61 ENTEROVIRUS INFECTION 1 0.0012
62 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
63 METASTASES TO ADRENALS 1 0.0011
64 SCROTAL SWELLING 1 0.0011
65 BLOOD UREA ABNORMAL 1 0.0011
66 PROSTATE INFECTION 1 0.0010
67 DACTYLITIS 1 0.0010
68 INFUSION SITE MASS 1 0.0009
69 PILOERECTION 1 0.0009
70 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
71 CRYPTORCHISM 1 0.0009
72 STRESS AT WORK 1 0.0009
73 HAEMATOCRIT INCREASED 2 0.0009
74 SURGICAL FAILURE 1 0.0009
75 ORAL SURGERY 2 0.0009
76 SINUS OPERATION 2 0.0008
77 WEIGHT ABNORMAL 2 0.0008
78 HYPERAESTHESIA TEETH 1 0.0008
79 LIBIDO DISORDER 1 0.0008
80 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
81 CALCULUS BLADDER 1 0.0007
82 BILIARY TRACT DISORDER 1 0.0007
83 CYSTIC FIBROSIS 4 0.0007
84 CHOLECYSTITIS INFECTIVE 2 0.0007
85 TRICHORRHEXIS 2 0.0007
86 RESPIRATORY SYMPTOM 2 0.0007
87 GENITAL RASH 1 0.0007
88 PULMONARY VALVE INCOMPETENCE 1 0.0007
89 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
90 STOMA SITE PAIN 1 0.0007
91 AXILLARY PAIN 1 0.0007
92 PELVIC INFLAMMATORY DISEASE 1 0.0007
93 MASTICATION DISORDER 2 0.0007
94 STOMA SITE HAEMORRHAGE 1 0.0006
95 LOCALISED OEDEMA 3 0.0006
96 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
97 OTITIS MEDIA 2 0.0006
98 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
99 MITRAL VALVE PROLAPSE 1 0.0006
100 GASTRIC DILATATION 1 0.0006
101 SEIZURE LIKE PHENOMENA 1 0.0006
102 MYCOBACTERIAL INFECTION 1 0.0006
103 VERTIGO POSITIONAL 1 0.0006
104 INFUSION SITE DISCHARGE 1 0.0006
105 BURNS SECOND DEGREE 1 0.0006
106 BRONCHIOLITIS 2 0.0006
107 PANCREATIC FAILURE 1 0.0006
108 GLOSSITIS 2 0.0006
109 AORTIC VALVE STENOSIS 1 0.0006
110 PLASMACYTOMA 1 0.0005
111 STOMA SITE ERYTHEMA 1 0.0005
112 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
113 BILE DUCT OBSTRUCTION 1 0.0005
114 FACE INJURY 2 0.0005
115 PANCREATIC CYST 1 0.0005
116 HEPATIC MASS 1 0.0005
117 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
118 EYELID PAIN 1 0.0005
119 PRE-EXISTING CONDITION IMPROVED 3 0.0005
120 DILATATION VENTRICULAR 1 0.0005
121 EAR SWELLING 1 0.0005
122 JAW FRACTURE 1 0.0005
123 INFUSION SITE BRUISING 1 0.0005
124 HORDEOLUM 2 0.0005
125 VITREOUS DETACHMENT 1 0.0005
126 FLATULENCE 26 0.0005
127 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
128 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
129 RESPIRATION ABNORMAL 3 0.0004
130 HAEMANGIOMA 1 0.0004
131 VOLVULUS 1 0.0004
132 URINARY HESITATION 1 0.0004
133 PAINFUL RESPIRATION 1 0.0004
134 VULVOVAGINAL PRURITUS 2 0.0004
135 ENDODONTIC PROCEDURE 1 0.0004
136 LACTOSE INTOLERANCE 1 0.0004
137 MEAN CELL VOLUME INCREASED 1 0.0004
138 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
139 ANIMAL BITE 1 0.0004
140 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
141 RHINITIS 3 0.0004
142 HIP SURGERY 2 0.0004
143 LIP BLISTER 1 0.0004
144 ON AND OFF PHENOMENON 2 0.0004
145 THERAPEUTIC RESPONSE DELAYED 1 0.0004
146 EJACULATION DISORDER 1 0.0004
147 PANCREATIC CARCINOMA METASTATIC 1 0.0004
148 CARDIAC VALVE DISEASE 2 0.0003
149 HEART VALVE INCOMPETENCE 1 0.0003
150 PULMONARY PAIN 1 0.0003
151 METABOLIC ENCEPHALOPATHY 1 0.0003
152 EMERGENCY CARE 1 0.0003
153 EMBOLISM VENOUS 1 0.0003
154 DUODENITIS 1 0.0003
155 BILE DUCT STONE 1 0.0003
156 STUPOR 1 0.0003
157 PLASMA CELL MYELOMA RECURRENT 1 0.0003
158 HEPATIC NEOPLASM 1 0.0003
159 PRODUCT SUPPLY ISSUE 2 0.0003
160 GASTROENTERITIS VIRAL 5 0.0003
161 RECTAL DISCHARGE 1 0.0003
162 FREEZING PHENOMENON 1 0.0003
163 NEURODERMATITIS 1 0.0003
164 PROTEIN TOTAL DECREASED 1 0.0003
165 PARANASAL SINUS HYPERSECRETION 1 0.0003
166 GASTRIC INFECTION 1 0.0003
167 BOWEL MOVEMENT IRREGULARITY 2 0.0003
168 CLAVICLE FRACTURE 1 0.0003
169 GINGIVAL DISORDER 1 0.0003
170 OESOPHAGEAL DISORDER 1 0.0003
171 MUSCULOSKELETAL CHEST PAIN 4 0.0003
172 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
173 FAECES HARD 1 0.0003
174 RHINOVIRUS INFECTION 1 0.0003
175 EPIGASTRIC DISCOMFORT 1 0.0003
176 CERVIX CARCINOMA 1 0.0003
177 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
178 PNEUMONIA FUNGAL 1 0.0003
179 OESOPHAGEAL PAIN 1 0.0003
180 HYPERPHAGIA 1 0.0003
181 SKIN PAPILLOMA 1 0.0002
182 ORGAN FAILURE 1 0.0002
183 FULL BLOOD COUNT DECREASED 5 0.0002
184 SPINAL FUSION SURGERY 1 0.0002
185 GOITRE 1 0.0002
186 ABNORMAL FAECES 2 0.0002
187 ILEUS 3 0.0002
188 HAIR COLOUR CHANGES 3 0.0002
189 CANDIDA INFECTION 4 0.0002
190 TONGUE DISCOMFORT 1 0.0002
191 AORTIC VALVE INCOMPETENCE 1 0.0002
192 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
193 PSEUDOMONAS INFECTION 2 0.0002
194 PLATELET COUNT INCREASED 3 0.0002
195 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
196 PULMONARY FUNCTION TEST DECREASED 1 0.0002
197 DYSPHEMIA 1 0.0002
198 PARONYCHIA 1 0.0002
199 HAEMORRHAGIC ANAEMIA 1 0.0002
200 GRIP STRENGTH DECREASED 2 0.0002
201 GINGIVAL SWELLING 1 0.0002
202 SINUS CONGESTION 3 0.0002
203 IMPAIRED GASTRIC EMPTYING 3 0.0002
204 INJECTION SITE PAPULE 1 0.0002
205 DISEASE COMPLICATION 1 0.0002
206 EAR DISORDER 1 0.0002
207 DIVERTICULITIS 6 0.0002
208 ROSACEA 1 0.0002
209 PERFORMANCE STATUS DECREASED 1 0.0002
210 UMBILICAL HERNIA 1 0.0002
211 SEASONAL ALLERGY 3 0.0002
212 SKIN ABRASION 1 0.0002
213 ENDOMETRIOSIS 1 0.0002
214 TUMOUR MARKER INCREASED 1 0.0002
215 APHAGIA 1 0.0002
216 VULVOVAGINAL PAIN 1 0.0002
217 FOOT OPERATION 1 0.0002
218 BLADDER DISORDER 2 0.0002
219 AMMONIA INCREASED 1 0.0002
220 INITIAL INSOMNIA 2 0.0002
221 PRODUCT COLOUR ISSUE 1 0.0002
222 DELUSION 3 0.0002
223 FOOD CRAVING 1 0.0002
224 RETCHING 4 0.0002
225 PRODUCT SIZE ISSUE 1 0.0002
226 GINGIVITIS 1 0.0002
227 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
228 FAECALOMA 1 0.0002
229 HYPERKERATOSIS 1 0.0002
230 PROSTATIC DISORDER 1 0.0002
231 HEART RATE ABNORMAL 1 0.0002
232 MALNUTRITION 2 0.0002
233 COLECTOMY 1 0.0002
234 MICTURITION URGENCY 2 0.0002
235 NEUROLOGICAL SYMPTOM 1 0.0002
236 CONSTIPATION 38 0.0002
237 HOT FLUSH 13 0.0002
238 ELECTROLYTE IMBALANCE 2 0.0002
239 SPLENOMEGALY 2 0.0002
240 HEAD DISCOMFORT 3 0.0002
241 BRADYKINESIA 1 0.0002
242 BLOOD IRON DECREASED 2 0.0002
243 BACTERAEMIA 2 0.0002
244 SYMPTOM RECURRENCE 1 0.0002
245 PLATELET COUNT ABNORMAL 1 0.0002
246 ADRENAL INSUFFICIENCY 2 0.0002
247 VULVOVAGINAL BURNING SENSATION 1 0.0002
248 DYSURIA 6 0.0002
249 SCOLIOSIS 1 0.0002
250 CHOLANGITIS 1 0.0002
251 AGEUSIA 4 0.0002
252 SECRETION DISCHARGE 2 0.0002
253 SWELLING OF EYELID 1 0.0002
254 INFUSION SITE SWELLING 1 0.0002
255 BLEPHAROSPASM 1 0.0002
256 MUSCLE ATROPHY 2 0.0002
257 SLEEP APNOEA SYNDROME 3 0.0002
258 FOREIGN BODY SENSATION IN EYES 1 0.0002
259 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
260 HYPOPHAGIA 4 0.0002
261 PROCTALGIA 1 0.0002
262 ERUCTATION 3 0.0002
263 HIATUS HERNIA 2 0.0002
264 EAR PAIN 3 0.0002
265 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
266 NODULE 2 0.0002
267 DYSGRAPHIA 1 0.0002
268 TOOTH INFECTION 2 0.0002
269 WALKING AID USER 1 0.0002
270 APPETITE DISORDER 1 0.0002
271 VIRAL INFECTION 5 0.0002
272 FUNGAL INFECTION 5 0.0001
273 CHOLECYSTITIS CHRONIC 1 0.0001
274 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
275 PRODUCT LABEL ISSUE 1 0.0001
276 ONYCHOCLASIS 1 0.0001
277 DROOLING 1 0.0001
278 HAIR GROWTH ABNORMAL 1 0.0001
279 ABDOMINAL DISTENSION 15 0.0001
280 MASS 2 0.0001
281 BLOOD TEST ABNORMAL 2 0.0001
282 SKIN REACTION 2 0.0001
283 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
284 INTENTIONAL UNDERDOSE 1 0.0001
285 MAJOR DEPRESSION 1 0.0001
286 DYSPHONIA 8 0.0001
287 SINUSITIS 14 0.0001
288 SURGERY 8 0.0001
289 ORAL DISORDER 1 0.0001
290 BLINDNESS TRANSIENT 1 0.0001
291 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
292 CEREBRAL DISORDER 1 0.0001
293 URINARY INCONTINENCE 4 0.0001
294 SNEEZING 3 0.0001
295 INTESTINAL OBSTRUCTION 5 0.0001
296 OSTEOPENIA 2 0.0001
297 PROCEDURAL COMPLICATION 1 0.0001
298 RENAL FAILURE CHRONIC 1 0.0001
299 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
300 CONCUSSION 1 0.0001
301 RASH PRURITIC 7 0.0001
302 GASTROINTESTINAL INFLAMMATION 1 0.0001
303 MULTIPLE ALLERGIES 1 0.0001
304 NASAL DISCOMFORT 1 0.0001
305 PNEUMOTHORAX 2 0.0001
306 RESPIRATORY TRACT CONGESTION 2 0.0001
307 TRICUSPID VALVE INCOMPETENCE 1 0.0001
308 LOCALISED INFECTION 3 0.0001
309 AMNESIA 8 0.0001
310 DECUBITUS ULCER 1 0.0001
311 POLYURIA 1 0.0001
312 HICCUPS 1 0.0001
313 SECOND PRIMARY MALIGNANCY 1 0.0001
314 SKIN DISORDER 4 0.0001
315 GAIT INABILITY 4 0.0001
316 FACIAL PARALYSIS 1 0.0001
317 PRODUCT CONTAINER ISSUE 1 0.0001
318 CARDIAC OPERATION 1 0.0001
319 MUSCULOSKELETAL DISCOMFORT 2 0.0001
320 PARANOIA 2 0.0001
321 STOMATITIS 7 0.0001
322 GASTRITIS 3 0.0001
323 SPINAL OSTEOARTHRITIS 1 0.0001
324 ANAL INCONTINENCE 1 0.0001
325 SKIN LESION 3 0.0001
326 NEPHROLITHIASIS 5 0.0001
327 PNEUMONIA BACTERIAL 1 0.0001
328 BRAIN NEOPLASM 1 0.0001
329 INCREASED TENDENCY TO BRUISE 1 0.0001
330 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
331 FEELING COLD 3 0.0001
332 HEPATIC ENCEPHALOPATHY 1 0.0001
333 COGNITIVE DISORDER 5 0.0001
334 BLISTER 6 0.0001
335 FLANK PAIN 1 0.0001
336 HEPATIC CIRRHOSIS 2 0.0001
337 EYE PAIN 6 0.0001
338 PHOTOPHOBIA 2 0.0001
339 BLOOD SODIUM DECREASED 2 0.0001
340 FOOT FRACTURE 2 0.0001
341 BLOOD URINE PRESENT 2 0.0001
342 PRODUCT PACKAGING ISSUE 1 0.0001
343 INTENTIONAL DOSE OMISSION 3 0.0001
344 FEELING JITTERY 2 0.0001
345 EYE INFLAMMATION 1 0.0001
346 ATELECTASIS 1 0.0001
347 DYSSTASIA 3 0.0001
348 PARKINSONISM 1 0.0001
349 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
350 VITAMIN D DEFICIENCY 1 0.0001
351 BONE PAIN 6 0.0001
352 PHARYNGEAL SWELLING 1 0.0001
353 NASAL CONGESTION 6 0.0001
354 ARTHRITIS 8 0.0001
355 WHEEZING 6 0.0001
356 LIGAMENT SPRAIN 1 0.0001
357 SINUS DISORDER 2 0.0001
358 INABILITY TO AFFORD MEDICATION 1 0.0001
359 GASTROINTESTINAL DISORDER 9 0.0001
360 PRESCRIBED UNDERDOSE 2 0.0001
361 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
362 EMPHYSEMA 1 0.0001
363 PRODUCT ADMINISTRATION ERROR 2 0.0001
364 TASTE DISORDER 2 0.0001
365 DEHYDRATION 13 0.0001
366 HYPERBILIRUBINAEMIA 1 0.0001
367 INTENTIONAL DRUG MISUSE 2 0.0001
368 WEIGHT FLUCTUATION 1 0.0001
369 SEIZURE 11 0.0001
370 INJECTION SITE DISCOMFORT 1 0.0001
371 SCRATCH 1 0.0001
372 RHINORRHOEA 6 0.0001
373 PHARYNGITIS STREPTOCOCCAL 1 0.0001
374 SKIN LACERATION 1 0.0001
375 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
376 OESOPHAGITIS 1 0.0001
377 BLOOD GLUCOSE FLUCTUATION 1 0.0001
378 TOOTH FRACTURE 1 0.0001
379 DECREASED APPETITE 21 0.0001
380 TOOTH DISORDER 2 0.0001
381 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
382 ABDOMINAL DISCOMFORT 15 0.0001
383 GLOSSODYNIA 2 0.0001
384 PULMONARY OEDEMA 4 0.0001
385 ORAL PAIN 2 0.0001
386 INTESTINAL PERFORATION 1 0.0001
387 ANGER 3 0.0001
388 HEART RATE IRREGULAR 2 0.0001
389 MITRAL VALVE INCOMPETENCE 1 0.0001
390 SCAB 1 0.0001
391 GASTRIC HAEMORRHAGE 1 0.0001
392 BLOOD CHOLESTEROL INCREASED 4 0.0001
393 SPINAL PAIN 1 0.0001
394 HYPOXIA 3 0.0001
395 COVID-19 PNEUMONIA 1 0.0001
396 PRODUCT PRESCRIBING ERROR 2 0.0001
397 CATARACT 5 0.0001
398 THERAPY INTERRUPTED 6 0.0001
399 HYPERLIPIDAEMIA 1 0.0001
400 BLOOD PRESSURE FLUCTUATION 2 0.0001
401 ASTHENIA 31 0.0001
402 NOCTURIA 1 0.0001
403 FIBROMYALGIA 2 0.0001
404 LUNG DISORDER 4 0.0001
405 PRODUCT DOSE OMISSION ISSUE 24 0.0001
406 MUSCLE SPASTICITY 1 0.0001
407 SMALL INTESTINAL OBSTRUCTION 1 0.0001
408 INFLUENZA 9 0.0001
409 PHARYNGITIS 1 0.0001
410 TOOTH EXTRACTION 1 0.0001
411 COVID-19 14 0.0001
412 DERMATITIS ALLERGIC 1 0.0001
413 HAEMATEMESIS 2 0.0001
414 WEIGHT DECREASED 22 0.0001
415 FATIGUE 61 0.0001
416 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
417 ABDOMINAL PAIN UPPER 16 0.0001
418 ILLNESS 8 0.0001
419 SKIN ULCER 2 0.0001
420 HAEMATOMA 2 0.0001
421 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
422 MUSCLE SPASMS 14 0.0001
423 JOINT STIFFNESS 2 0.0001
424 URINARY TRACT INFECTION 13 0.0001
425 BEDRIDDEN 1 0.0001
426 ORAL CANDIDIASIS 1 0.0001
427 PULMONARY CONGESTION 1 0.0001
428 ADVERSE REACTION 1 0.0001
429 COUGH 21 0.0001
430 THROMBOSIS 6 0.0001
431 JOINT RANGE OF MOTION DECREASED 1 0.0001
432 QUALITY OF LIFE DECREASED 1 0.0001
433 DRY MOUTH 6 0.0001
434 THROAT TIGHTNESS 2 0.0001
435 UVEITIS 1 0.0001
436 BLINDNESS 3 0.0001
437 PERIPHERAL COLDNESS 1 0.0001
438 DIARRHOEA 47 0.0001
439 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
440 ORAL DISCOMFORT 1 0.0001
441 POLLAKIURIA 3 0.0001
442 HUNGER 1 0.0001
443 APHONIA 1 0.0001
444 CARPAL TUNNEL SYNDROME 1 0.0001
445 DEVICE OCCLUSION 1 0.0001
446 BLINDNESS UNILATERAL 1 0.0001
447 HEART RATE INCREASED 7 0.0001
448 ANGINA PECTORIS 2 0.0001
449 LETHARGY 4 0.0001
450 HYPERTHYROIDISM 1 0.0001
451 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
452 SEPTIC SHOCK 3 0.0001
453 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
454 FLUID OVERLOAD 1 0.0001
455 NEEDLE ISSUE 2 0.0001
456 RESPIRATORY FAILURE 5 0.0001
457 GASTROENTERITIS 1 0.0001
458 ASCITES 2 0.0001
459 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
460 SKIN HAEMORRHAGE 1 0.0001
461 PULMONARY MASS 1 0.0001
462 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
463 IRRITABILITY 4 0.0001
464 HALLUCINATION 5 0.0001
465 TREMOR 11 0.0001
466 LACRIMATION INCREASED 2 0.0001
467 UNEVALUABLE EVENT 5 0.0001
468 VERTIGO 4 0.0001
469 DIABETES MELLITUS 5 0.0001
470 MEMORY IMPAIRMENT 9 0.0001
471 DEVICE RELATED INFECTION 1 0.0001
472 LYMPHOMA 1 0.0001
473 FEMUR FRACTURE 2 0.0001
474 VISUAL IMPAIRMENT 8 0.0001
475 NAUSEA 51 0.0001
476 LUNG INFECTION 1 0.0001
477 ACUTE MYELOID LEUKAEMIA 1 0.0001
478 BASAL CELL CARCINOMA 1 0.0001
479 VOMITING 30 0.0001
480 BRAIN FOG 1 0.0001
481 PRODUCT USE COMPLAINT 1 0.0001
482 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
483 DYSPHAGIA 6 0.0001
484 ULCER 1 0.0001
485 ABSCESS 1 0.0001
486 NIGHT SWEATS 2 0.0001
487 MUSCULAR WEAKNESS 7 0.0001
488 BLOOD POTASSIUM INCREASED 1 0.0001
489 BACK DISORDER 1 0.0001
490 CHOLELITHIASIS 2 0.0001
491 METASTASES TO BONE 1 0.0001
492 DRY EYE 3 0.0001
493 SKIN EXFOLIATION 5 0.0001
494 FLUID RETENTION 3 0.0001
495 MYALGIA 10 0.0001
496 HEPATIC ENZYME INCREASED 4 0.0001
497 HOSPITALISATION 9 0.0001
498 PERIPHERAL SWELLING 9 0.0001
499 GASTRIC DISORDER 2 0.0001
500 MULTI-ORGAN FAILURE 1 0.0001
501 ORTHOSTATIC HYPOTENSION 1 0.0001
502 SPEECH DISORDER 3 0.0001
503 DEVICE USE ISSUE 1 0.0001
504 DEPRESSION 13 0.0001
505 HEART RATE DECREASED 2 0.0001
506 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
507 DYSPNOEA 32 0.0001
508 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
509 INSOMNIA 15 0.0001
510 GALLBLADDER DISORDER 1 0.0001
511 THIRST 1 0.0001
512 ADVERSE DRUG REACTION 5 0.0001
513 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
514 TOOTHACHE 1 0.0001
515 CRYING 2 0.0001
516 PANIC ATTACK 2 0.0001
517 UNDERDOSE 4 0.0001
518 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
519 AGITATION 4 0.0001
520 PAIN IN EXTREMITY 16 0.0001
521 ADVERSE EVENT 5 0.0001
522 NASOPHARYNGITIS 10 0.0001
523 OROPHARYNGEAL PAIN 5 0.0001
524 DYSGEUSIA 4 0.0001
525 SEPSIS 6 0.0001
526 EYE SWELLING 2 0.0001
527 NECK PAIN 3 0.0001
528 FRACTURE 1 0.0001
529 NEUROPATHY PERIPHERAL 5 0.0001
530 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
531 INCREASED APPETITE 1 0.0001
532 GAIT DISTURBANCE 10 0.0001
533 EYE IRRITATION 3 0.0001
534 ACUTE RESPIRATORY FAILURE 1 0.0001
535 CONTUSION 5 0.0001
536 HERNIA 1 0.0001
537 PRESCRIBED OVERDOSE 1 0.0001
538 DYSTONIA 1 0.0001
539 PALPITATIONS 6 0.0001
540 SKIN FISSURES 1 0.0001
541 FALL 17 0.0001
542 VISION BLURRED 7 0.0001
543 KIDNEY INFECTION 1 0.0001
544 DISABILITY 1 0.0001
545 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
546 ABNORMAL BEHAVIOUR 2 0.0001
547 UPPER LIMB FRACTURE 1 0.0001
548 CARDIAC FAILURE CONGESTIVE 4 0.0000
549 THERAPEUTIC RESPONSE DECREASED 3 0.0000
550 FEEDING DISORDER 1 0.0000
551 PLEURAL EFFUSION 3 0.0000
552 PSORIATIC ARTHROPATHY 2 0.0000
553 OEDEMA PERIPHERAL 6 0.0000
554 INJURY ASSOCIATED WITH DEVICE 1 0.0000
555 BODY TEMPERATURE INCREASED 1 0.0000
556 HAEMOGLOBIN DECREASED 5 0.0000
557 RIB FRACTURE 1 0.0000
558 CHEST PAIN 9 0.0000
559 TOOTH LOSS 1 0.0000
560 PULMONARY HYPERTENSION 1 0.0000
561 ROAD TRAFFIC ACCIDENT 2 0.0000
562 HALLUCINATION, VISUAL 1 0.0000
563 BACK PAIN 11 0.0000
564 HYPOAESTHESIA 7 0.0000
565 IRRITABLE BOWEL SYNDROME 1 0.0000
566 HYPOACUSIS 2 0.0000
567 BALANCE DISORDER 4 0.0000
568 FAECES DISCOLOURED 1 0.0000
569 CONDITION AGGRAVATED 14 0.0000
570 PRODUCT DISPENSING ERROR 1 0.0000
571 PRODUCT PRESCRIBING ISSUE 1 0.0000
572 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
573 ARTHRALGIA 19 0.0000
574 RENAL FAILURE 6 0.0000
575 RASH PAPULAR 1 0.0000
576 DEVICE ISSUE 4 0.0000
577 THROAT IRRITATION 2 0.0000
578 PARAESTHESIA 7 0.0000
579 ASTHMA 5 0.0000
580 INJECTION SITE REACTION 3 0.0000
581 SKIN DISCOLOURATION 2 0.0000
582 SHOCK 1 0.0000
583 PERICARDIAL EFFUSION 1 0.0000
584 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
585 CARDIAC DISORDER 4 0.0000
586 CHILLS 5 0.0000
587 DISEASE PROGRESSION 5 0.0000
588 ANXIETY 12 0.0000
589 PRODUCTIVE COUGH 2 0.0000
590 MOBILITY DECREASED 3 0.0000
591 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
592 HEPATIC CANCER 1 0.0000
593 NEURALGIA 1 0.0000
594 DYSPEPSIA 4 0.0000
595 BRONCHITIS 3 0.0000
596 ABASIA 1 0.0000
597 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
598 WEIGHT INCREASED 9 0.0000
599 EPISTAXIS 3 0.0000
600 LEUKOPENIA 2 0.0000
601 CELLULITIS 2 0.0000
602 CHRONIC KIDNEY DISEASE 3 0.0000
603 PAIN 24 0.0000
604 CHEST DISCOMFORT 4 0.0000
605 PRURITUS 15 0.0000
606 LOSS OF CONSCIOUSNESS 5 0.0000
607 ANAPHYLACTIC SHOCK 1 0.0000
608 MALAISE 17 0.0000
609 INFLAMMATION 2 0.0000
610 UNRESPONSIVE TO STIMULI 1 0.0000
611 ABDOMINAL PAIN 9 0.0000
612 EXPOSURE VIA SKIN CONTACT 1 0.0000
613 DIPLOPIA 1 0.0000
614 RESPIRATORY TRACT INFECTION 1 0.0000
615 NERVOUSNESS 2 0.0000
616 DEAFNESS 1 0.0000
617 MUCOSAL INFLAMMATION 1 0.0000
618 MUSCULOSKELETAL PAIN 2 0.0000
619 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
620 ANHEDONIA 1 0.0000
621 DRUG INTERACTION 6 0.0000
622 INJECTION SITE BRUISING 3 0.0000
623 CONFUSIONAL STATE 6 0.0000
624 FREQUENT BOWEL MOVEMENTS 1 0.0000
625 OEDEMA 2 0.0000
626 LIMB INJURY 1 0.0000
627 PALLOR 1 0.0000
628 HEADACHE 23 0.0000
629 MOOD ALTERED 1 0.0000
630 INFLUENZA LIKE ILLNESS 3 0.0000
631 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
632 ABNORMAL DREAMS 1 0.0000
633 DEMENTIA 1 0.0000
634 OXYGEN SATURATION DECREASED 2 0.0000
635 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
636 PAIN IN JAW 1 0.0000
637 RED BLOOD CELL COUNT DECREASED 1 0.0000
638 HERPES ZOSTER 2 0.0000
639 PYREXIA 12 0.0000
640 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
641 INFECTION 5 0.0000
642 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
643 PNEUMONIA 11 0.0000
644 ACUTE MYOCARDIAL INFARCTION 1 0.0000
645 LABORATORY TEST ABNORMAL 1 0.0000
646 PSYCHOTIC DISORDER 1 0.0000
647 OESOPHAGEAL CARCINOMA 1 0.0000
648 FEELING ABNORMAL 8 0.0000
649 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
650 BLOOD POTASSIUM DECREASED 1 0.0000
651 APHASIA 1 0.0000
652 HYPERTENSION 7 0.0000
653 CORONARY ARTERY DISEASE 1 0.0000
654 BLOOD PRESSURE INCREASED 5 0.0000
655 FEELING HOT 2 0.0000
656 DRUG ADMINISTRATION ERROR 1 0.0000
657 GYNAECOMASTIA 1 0.0000
658 HYPERSENSITIVITY 6 0.0000
659 LIMB DISCOMFORT 1 0.0000
660 RASH 14 0.0000
661 DIZZINESS 16 0.0000
662 SWELLING 3 0.0000
663 NERVOUS SYSTEM DISORDER 1 0.0000
664 HEAD INJURY 1 0.0000
665 MIGRAINE 3 0.0000
666 CYSTITIS 1 0.0000
667 PRODUCT DOSE OMISSION 2 0.0000
668 BLOOD CREATININE INCREASED 2 0.0000
669 ALOPECIA 6 0.0000
670 EYE DISORDER 1 0.0000
671 DEATH 26 0.0000
672 FEBRILE NEUTROPENIA 2 0.0000
673 BLOOD PRESSURE DECREASED 2 0.0000
674 URINARY RETENTION 1 0.0000
675 DRY SKIN 4 0.0000
676 SOMNOLENCE 6 0.0000
677 EYE PRURITUS 1 0.0000
678 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
679 FLUSHING 3 0.0000
680 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
681 NIGHTMARE 1 0.0000
682 DELIRIUM 1 0.0000
683 NEOPLASM PROGRESSION 1 0.0000
684 RASH MACULAR 1 0.0000
685 HYPERKALAEMIA 1 0.0000
686 INJURY 2 0.0000
687 SLEEP DISORDER 2 0.0000
688 PLATELET COUNT DECREASED 3 0.0000
689 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
690 OVERDOSE 6 0.0000
691 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
692 ACCIDENTAL OVERDOSE 1 0.0000
693 RESTLESSNESS 1 0.0000
694 DYSARTHRIA 1 0.0000
695 DYSPNOEA EXERTIONAL 1 0.0000
696 COLITIS 1 0.0000
697 ANAEMIA 5 0.0000
698 INJECTION SITE SWELLING 2 0.0000
699 PLASMA CELL MYELOMA 1 0.0000
700 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
701 HYPOTENSION 5 0.0000
702 EMOTIONAL DISTRESS 3 0.0000
703 EXTRA DOSE ADMINISTERED 1 0.0000
704 NEUTROPHIL COUNT DECREASED 1 0.0000
705 OSTEOPOROSIS 1 0.0000
706 DRUG DOSE OMISSION 4 0.0000
707 OFF LABEL USE 21 0.0000
708 WITHDRAWAL SYNDROME 1 0.0000
709 TOXICITY TO VARIOUS AGENTS 4 0.0000
710 CEREBROVASCULAR ACCIDENT 4 0.0000
711 OSTEOARTHRITIS 1 0.0000
712 RECTAL HAEMORRHAGE 1 0.0000
713 DEVICE LEAKAGE 1 0.0000
714 INTENTIONAL PRODUCT MISUSE 2 0.0000
715 MUSCULOSKELETAL STIFFNESS 2 0.0000
716 COLITIS ULCERATIVE 1 0.0000
717 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
718 SKIN IRRITATION 1 0.0000
719 TINNITUS 1 0.0000
720 HYPOKALAEMIA 1 0.0000
721 RENAL DISORDER 1 0.0000
722 BREAST CANCER 2 0.0000
723 OCULAR HYPERAEMIA 1 0.0000
724 PULMONARY EMBOLISM 2 0.0000
725 MULTIPLE SCLEROSIS 1 0.0000
726 ATRIAL FIBRILLATION 2 0.0000
727 AGGRESSION 1 0.0000
728 THERAPY CESSATION 1 0.0000
729 ERYTHEMA 4 0.0000
730 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
731 DERMATITIS ATOPIC 1 0.0000
732 BRADYCARDIA 1 0.0000
733 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
734 TREATMENT NONCOMPLIANCE 1 0.0000
735 ANAPHYLACTIC REACTION 1 0.0000
736 ARTHROPATHY 1 0.0000
737 MEDICATION ERROR 1 0.0000
738 THROMBOCYTOPENIA 2 0.0000
739 HYPONATRAEMIA 1 0.0000
740 PRODUCT SUBSTITUTION ISSUE 1 0.0000
741 JOINT SWELLING 2 0.0000
742 NO ADVERSE EVENT 3 0.0000
743 ILL-DEFINED DISORDER 1 0.0000
744 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
745 PRODUCT USE ISSUE 3 0.0000
746 BLOOD GLUCOSE INCREASED 3 0.0000
747 INTENTIONAL OVERDOSE 1 0.0000
748 DEEP VEIN THROMBOSIS 1 0.0000
749 SWELLING FACE 1 0.0000
750 INJECTION SITE PRURITUS 1 0.0000
751 PRODUCT QUALITY ISSUE 2 0.0000
752 BURNING SENSATION 1 0.0000
753 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
754 SKIN BURNING SENSATION 1 0.0000
755 DRUG INEFFECTIVE 18 0.0000
756 ACUTE KIDNEY INJURY 2 0.0000
757 INJECTION SITE PAIN 4 0.0000
758 INJECTION SITE HAEMORRHAGE 1 0.0000
759 PROSTATE CANCER 1 0.0000
760 CARDIAC ARREST 1 0.0000
761 COMPLETED SUICIDE 1 0.0000
762 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
763 URTICARIA 2 0.0000
764 RENAL IMPAIRMENT 1 0.0000
765 PRODUCT STORAGE ERROR 1 0.0000
766 TACHYCARDIA 1 0.0000
767 SUICIDAL IDEATION 1 0.0000
768 DRUG INTOLERANCE 1 0.0000
769 SYNCOPE 1 0.0000
770 HAEMORRHAGE 1 0.0000
771 INJECTION SITE ERYTHEMA 1 0.0000
772 HYPERHIDROSIS 1 0.0000
773 PSORIASIS 1 0.0000
774 NEUTROPENIA 1 0.0000
775 INCORRECT DOSE ADMINISTERED 1 0.0000